Entyvio

(vedolizumab)
Entyvio 300 MG Injection
NO BLACK BOX WARNING

Dosage & administration

drug label

Entyvio prescribing information

prior authorization

Entyvio prior authorization resources

Most recent Entyvio prior authorization forms

View By Payer
Verified: Oct 02, 2023Blue Cross Blue Shield of Michigan - FEP Entyvio Prior Authorization Form (Medical Benefit)
Verified: Sep 27, 2023Cigna - Entyvio Prior Authorization Form
Verified: Sep 26, 2023Blue Cross Blue Shield of Michigan - Entyvio Prior Authorization Form (Medical Benefit)
Verified: Sep 21, 2023Aetna - Entyvio Prior Authorization Form
Verified: Sep 20, 2023Aetna - Medicare Part B Entyvio Prior Authorization Form

OTHER
Complete Letter of Medical Necessity

OTHER
Coverage Authorization Appeals

OTHER
Appeal Letter For Rejected Claim
Learn More

Benefits investigation

PDF
Entyvio Connect Enrollment Form
Learn More

Reimbursement help (FRM)

PDF
Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

financial assistance

Entyvio financial assistance options

Co-pay savings program

commercial only

PDF
Entyvio Connect Enrollment Form
Enroll in Patient Savings Program

PDF
Co-Pay Claim Form
Learn More

Bridge program

commercial only

PDF
Entyvio Connect Enrollment Form

OTHER
Start Program [Awaiting Approval]

OTHER
Bridge Program [Temporary loss or gap in coverage]
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+

PDF
Patient Assistance Application Form
Learn More

patient education

Entyvio patient education

Getting started on Entyvio

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

PDF
Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Brochure- Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Infusion Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Entyvio Connect Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Doctor Discussion Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
About Entyvio
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

VIDEO
Patient Stories
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Receiving Entyvio: Ulcerative Colitis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Receiving Entyvio: Crohn's Disease
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Continuing Treatment - Traveling
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Learn More

people also ask

Entyvio FAQs

Is there a pregnancy exposure registry for ENTYVIO?Yes, there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to ENTYVIO during pregnancy. For more information, you can call 1-877-TAKEDA-7 (1-877-825-3327).
What is the risk of using ENTYVIO during pregnancy?Available pharmacovigilance data, data from the ongoing pregnancy registry, and data from published case reports and cohort studies in pregnant women have not identified an ENTYVIO associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. However, there are risks to the mother and the fetus associated with inflammatory bowel disease in pregnancy. It is important to consider these risks in addition to the benefits of using ENTYVIO.
What are the risks associated with inflammatory bowel disease (IBD) in pregnancy?Published data suggest that the risk of adverse pregnancy outcomes in women with IBD is associated with increased disease activity. Adverse pregnancy outcomes include preterm delivery (before 37 weeks of gestation), low birth weight (less than 2,500 g) infants, and small for gestational age at birth.
Can ENTYVIO affect immune responses in newborns and infants?ENTYVIO administered during pregnancy could affect immune responses in the in utero-exposed newborn and infant. The clinical significance of low levels of ENTYVIO in utero-exposed infants is unknown. The safety of administering live or live-attenuated vaccines in exposed infants is also unknown.
Is it safe to use ENTYVIO while breastfeeding?Data from a clinical lactation study show the presence of vedolizumab (the active ingredient in ENTYVIO) in human milk. Systemic exposure in a breastfed infant is expected to be low because monoclonal antibodies are largely degraded in the gastrointestinal tract. There are no data on the effects of vedolizumab on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for ENTYVIO and any potential adverse effects on the breastfed infant from ENTYVIO or from the underlying maternal condition.
Is ENTYVIO safe for use in pediatric patients?Safety and effectiveness of ENTYVIO in pediatric patients have not been established.
Is ENTYVIO safe for use in geriatric patients?Clinical trials of ENTYVIO did not include sufficient numbers of subjects aged 65 and over.
FAQ Data Source